Machine Learning Algorithm to Estimate Distant Breast Cancer Recurrence at the Population Level with Administrative Data

References

• Gourgou-Bourgade S, Cameron D, Poortmans P, et al. Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). Ann Oncol. 2015;26(5):873–879. doi:10.1093/annonc/mdv106
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228–247. doi:10.1016/j.ejca.2008.10.026
   PubMed Web of Science ®Google Scholar
• Warren JL, Yabroff KR. Challenges and opportunities in measuring cancer recurrence in the United States. J Natl Cancer Inst. 2015;107:djv134–djv134. doi:10.1093/jnci/djv134
   PubMedGoogle Scholar
• Negoita S, Ramirez-Pena E. Prevention of late recurrence: an increasingly important target for breast cancer research and control. J Natl Cancer Inst. 2021. doi:10.1093/JNCI/DJAB203
   Google Scholar
• Izci H, Tambuyzer T, Tuand K, et al. A systematic review of estimating breast cancer recurrence at the population level with administrative data. J Natl Cancer Inst. 2020;112:979–988. doi:10.1093/jnci/djaa050
   PubMedGoogle Scholar
• Ritzwoller DP, Hassett MJ, Uno H, et al. Development, validation, and dissemination of a breast cancer recurrence detection and timing informatics algorithm. J Natl Cancer Inst. 2018;110:273–281. doi:10.1093/jnci/djx200
   PubMedGoogle Scholar
• A’mar T, Beatty JD, Fedorenko C, et al. Incorporating breast cancer recurrence events into population-based cancer registries using medical claims: cohort study. JMIR Cancer. 2020;6(2):1–10.
   Web of Science ®Google Scholar
• Cairncrossh ZF, Nelson G, Shack L, Metcalfe A. Validation in Alberta of an administrative data algorithm to identify cancer recurrence. Curr Oncol. 2020;27(3):e343–e346. doi:10.3747/co.27.5861
   PubMed Web of Science ®Google Scholar
• Lambert P, Pitz M, Singh H, Decker K. Evaluation of algorithms using administrative health and structured electronic medical record data to determine breast and colorectal cancer recurrence in a Canadian province: using algorithms to determine breast and colorectal cancer recurrence. BMC Cancer. 2021;21(1):1–10. doi:10.1186/s12885-021-08526-9
   PubMed Web of Science ®Google Scholar
• Pedersen RN, Öztürk B, Mellemkjær L, et al. Validation of an algorithm to ascertain late breast cancer recurrence using Danish medical registries. Clin Epidemiol. 2020;12:1083–1093. doi:10.2147/CLEP.S269962
   PubMed Web of Science ®Google Scholar
• Rasmussen LA, Jensen H, Virgilsen LF, et al. A validated algorithm for register-based identification of patients with recurrence of breast cancer-Based on Danish Breast Cancer Group (DBCG) data. CANCER Epidemiol. 2019;59:129–134. doi:10.1016/j.canep.2019.01.016
   PubMed Web of Science ®Google Scholar
• Valachis A, Carlqvist P, Szilcz M, et al. Use of classifiers to optimise the identification and characterisation of metastatic breast cancer in a nationwide administrative registry. Acta Oncol. 2021;60(12):1604–1610. doi:10.1080/0284186X.2021.1979645
   PubMed Web of Science ®Google Scholar
• Steyerberg EW, Vergouwe Y. Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J. 2014;35:1925–1931. doi:10.1093/eurheartj/ehu207
   PubMed Web of Science ®Google Scholar
• Het Intermutualistisch Agentschap [The Intermutualistic Agency] (IMA) L’Agence InterMutualiste (AIM). https://ima-aim.be/.
   Google Scholar
• Technische Cel voor het beheer van de MZG-MFG data [Technical cel for management of MZG-MFG data]- La Cellule Technique pour la gestion des données RHM-RFM. https://tct.fgov.be/.
   Google Scholar
• CBSS - Crossroads Bank for Social Security. Available from: https://www.ksz-bcss.fgov.be/nl/documents-list. Accessed April 28, 2023.
   Google Scholar
• Agence pour une Vie de Qualité [Walloon Agency for quality of life] (AViQ). https://www.aviq.be/.
   Google Scholar
• Smits N. A note on Youden’s J and its cost ratio. BMC Med Res Methodol. 2010;10(1):1–4. doi:10.1186/1471-2288-10-89
   PubMedGoogle Scholar
• Sutton CD. Classification and regression trees, bagging, and boosting. Handb Stat. 2005;24:303–329.
   Google Scholar
• Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and regression trees. Classif Regres Trees. 1984;20:1–358.
   Google Scholar
• Chen Y, Yang Y. The one standard error rule for model selection: does it work? Stats. 2021;4(4):868–892. doi:10.3390/stats4040051
   Google Scholar
• Enger SM, Soe ST, Buist DSM, et al. Breast cancer treatment of older women in integrated health care settings. J Clin Oncol. 2006;24(27):4377–4383. doi:10.1200/JCO.2006.06.3065
   PubMed Web of Science ®Google Scholar
• Han Y, Sui Z, Jia Y, et al. Metastasis patterns and prognosis in breast cancer patients aged ≥ 80 years: a SEER database analysis. J Cancer. 2021;12(21):6445. doi:10.7150/jca.63813
   PubMed Web of Science ®Google Scholar
• Xu Y, Kong S, Cheung WY, et al. Development and validation of case-finding algorithms for recurrence of breast cancer using routinely collected administrative data. BMC Cancer. 2019;19(1):1–10. doi:10.1186/s12885-019-5432-8
   PubMedGoogle Scholar
• Chubak J, Onega T, Zhu W, et al. An electronic health record-based algorithm to ascertain the date of second breast cancer events. Med Care. 2017;55:e81–e87. doi:10.1097/MLR.0000000000000352
   PubMed Web of Science ®Google Scholar
• Kroenke CH, Chubak J, Johnson L, et al. Enhancing breast cancer recurrence algorithms through selective use of medical record data. J Natl Cancer Inst. 2016;108. doi:10.1093/jnci/djv336
   PubMedGoogle Scholar
• Cronin-Fenton D, Kjærsgaard A, Nørgaard M, et al. Breast cancer recurrence, bone metastases, and visceral metastases in women with stage II and III breast cancer in Denmark. Breast Cancer Res Treat. 2018;167(2):517–528. doi:10.1007/s10549-017-4510-3
   PubMed Web of Science ®Google Scholar
• In H, Bilimoria KY, Stewart AK, et al. Cancer recurrence: an important but missing variable in national cancer registries. Ann Surg Oncol. 2014;21(5):1520–1529. doi:10.1245/s10434-014-3516-x
   PubMed Web of Science ®Google Scholar
• Nout RA, Fiets WE, Struikmans H, et al. The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer. Breast Cancer Res Treat. 2008;109(3):567–572. doi:10.1007/s10549-007-9681-x
   PubMed Web of Science ®Google Scholar
• Chubak J, Yu O, Pocobelli G, et al. Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer. J Natl Cancer Inst. 2012;104(12):931–940. doi:10.1093/jnci/djs233
   PubMedGoogle Scholar
• Nordstrom B, Whyte J, Stolar M, Catherine Mercaldi JK, Kallich JD. Identification of metastatic cancer in claims data. Pharmacoepidemiology. 2012;21(2):21–28. doi:10.1002/pds.3247
   Google Scholar
• Nordstrom BL, Simeone JC, Malley KG, et al. Validation of claims algorithms for progression to metastatic cancer in patients with breast, non-small cell lung, and colorectal cancer. Pharmacoepidemiol Drug Saf. 2015;24(1, SI):511.
   Google Scholar
• Pedersen RN, Oztü Rk Esen B€, Mellemkjaer L, et al. The incidence of breast cancer recurrence 10–32 years after primary diagnosis. J Natl Cancer Inst. 2021. doi:10.1093/JNCI/DJAB202
   Google Scholar
• Lamont EB, Ii JEH, Weeks JC, et al. Measuring disease-free survival and cancer relapse using medicare claims from CALGB breast cancer trial participants (Companion to 9344). J Natl Cancer Inst. 2006;98(18):1335–1338. doi:10.1093/jnci/djj363
   PubMedGoogle Scholar
• Chawla N, Yabroff KR, Mariotto A, et al. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage. Ann Epidemiol. 2014;24(9):666–672.e2. doi:10.1016/j.annepidem.2014.06.099
   PubMed Web of Science ®Google Scholar
• Hassett MJ, Ritzwoller DP, Taback N, et al. Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts. Med Care. 2014;52(10):e65–e73. doi:10.1097/MLR.0b013e318277eb6f
   PubMed Web of Science ®Google Scholar
• Sathiakumar N, Delzell E, Yun H, et al. Accuracy of medicare claim-based algorithm to detect breast, prostate, or lung cancer bone metastases. Med Care. 2017;55:e144–e149. doi:10.1097/MLR.0000000000000539
   PubMed Web of Science ®Google Scholar
• McClish D, Penberthy L, Pugh A. Using Medicare claims to identify second primary cancers and recurrences in order to supplement a cancer registry. J Clin Epidemiol. 2003;56(8):760–767. doi:10.1016/S0895-4356(03)00091-X
   PubMed Web of Science ®Google Scholar